---
title: Assessing the Potential of HPV16 E6 Seroprevalence as a Biomarker for Anal
  Dysplasia and Cancer Screening-A Systematic Review and Meta-Analysis
date: '2024-03-28'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38542409/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240328180704&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Elevated rates of human papillomavirus (HPV)-related anal high-grade
  squamous intraepithelial lesions (HSIL) and anal cancer (AC) in populations like
  men who have sex with men (MSM) living with HIV underscore the need for effective
  screening. While high-resolution anoscopy-guided biopsy is the gold standard, limited
  provider availability poses a challenge. This has spurred interest in identifying
  biomarkers for improved AC prevention. Antibodies against HPV16 oncoprotein E6,
  known as markers ...
disable_comments: true
---
Elevated rates of human papillomavirus (HPV)-related anal high-grade squamous intraepithelial lesions (HSIL) and anal cancer (AC) in populations like men who have sex with men (MSM) living with HIV underscore the need for effective screening. While high-resolution anoscopy-guided biopsy is the gold standard, limited provider availability poses a challenge. This has spurred interest in identifying biomarkers for improved AC prevention. Antibodies against HPV16 oncoprotein E6, known as markers ...